Issue
Alert me when new journal issues are available via
Editorial board page ii Full-Text PDF (26 KB)
In this issue page xi Full-Text PDF (24 KB)
pages xii-xiii Full-Text PDF (22 KB)
News pages 2587-2591 Full-Text PDF (183 KB)
Editorial Comment
Getting there? Salvage therapy for refractory Langerhans cell histiocytosis in children Sheila Weitzman, Jon Pritchard pages 2592-2594 Full Text | Full-Text PDF (78 KB)
Current Perspective
Primary prevention of human papillomavirus-dependent neoplasia: No condom, no sex Richard J. Epstein pages 2595-2600 Abstract | Full Text | Full-Text PDF (127 KB)
Reviews
Evaluating erythropoietic agents for the treatment of anaemia in the oncology setting Pere Gascón pages 2601-2612 Abstract | Full Text | Full-Text PDF (190 KB)
Quality of life among long-term breast cancer survivors: A systematic review Floortje Mols, Ad J.J.M. Vingerhoets, Jan Willem Coebergh, Lonneke V. van de Poll-Franse pages 2613-2619 Abstract | Full Text | Full-Text PDF (126 KB)
The Notch pathway in cancer: Differentiation gone awry Jonas Sjölund, Christina Manetopoulos, Marie-Thérése Stockhausen, Håkan Axelson pages 2620-2629 Abstract | Full Text | Full-Text PDF (376 KB)
Clinical Oncology
Fludarabine phosphate–CVP in patients over 60 years of age with advanced, low-grade and follicular lymphoma: A dose-finding study Pierre Soubeyran, Alain Monnereau, Houchingue Eghbali, Isabelle Soubeyran, Michèle Kind, Laurent Cany, Elizabeth Buy, Odile Guibon, Bernard Hœrni pages 2630-2636 Abstract | Full Text | Full-Text PDF (152 KB)
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer A.C. Voogd, F.J. van Oost, E.J.T. Rutgers, P.H.M. Elkhuizen, A.N. van Geel, L.J.E.E. Scheijmans, M.J.C. van der Sangen, G. Botke, C.J. Hoekstra, J.J. Jobsen, C.J.H. van de Velde, M.F. von Meyenfeldt, J.M. Tabak, J.L. Peterse, M.J. van de Vijver, J.W.W. Coebergh, G. van Tienhoven, for the Dutch Study Group on Local Recurrence after Breast Conservation (BORST Group) pages 2637-2644 Abstract | Full Text | Full-Text PDF (133 KB)
Inflammation and prognosis in colorectal cancer Kai Klintrup, Johanna M. Mäkinen, Saila Kauppila, Päivi O. Väre, Jukka Melkko, Hannu Tuominen, Karoliina Tuppurainen, Jyrki Mäkelä, Tuomo J. Karttunen, Markus J. Mäkinen pages 2645-2654 Abstract | Full Text | Full-Text PDF (620 KB)
Fulvestrant (‘Faslodex’) in pre-treated patients with advanced breast cancer: A single-centre experience G.G. Steger, R. Bartsch, C. Wenzel, U. Pluschnig, D. Hussian, U. Sevelda, G.J. Locker, M.F. Gnant, R. Jakesz, C.C. Zielinski pages 2655-2661 Abstract | Full Text | Full-Text PDF (139 KB)
Patients at high risk of progression after radical prostatectomy: Do they all benefit from immediate post-operative irradiation? (EORTC trial 22911) Laurence Collette, Hein van Poppel, Michel Bolla, Paul van Cangh, Kris Vekemans, Luigi Da Pozzo, Theo M. de Reijke, Antony Verbaeys, Jean-François Bosset, Marianne Piérart, for the European Organisation for Research and Treatment of Cancer (EORTC) Radiotherapy and Genito-urinary Groups pages 2662-2672 Abstract | Full Text | Full-Text PDF (163 KB)
Vaginal oestrogen therapy after breast cancer: Is it safe? Riccardo Ponzone, Nicoletta Biglia, Maria Elena Jacomuzzi, Furio Maggiorotto, Luca Mariani, Piero Sismondi pages 2673-2681 Abstract | Full Text | Full-Text PDF (150 KB)
Paediatric Oncology
Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction F. Bernard, C. Thomas, Y. Bertrand, M. Munzer, J. Landman Parker, M. Ouache, V. Minard Colin, Y. Perel, P. Chastagner, C. Vermylen, J. Donadieu pages 2682-2689 Abstract | Full Text | Full-Text PDF (124 KB)
Paediatric Update
Preventing organ-specific chemotherapy toxicity Jill P. Ginsberg, Richard B. Womer pages 2690-2700 Abstract | Full Text | Full-Text PDF (167 KB)
Cure at what cost? Michael C.G. Stevens pages 2701-2703 Full Text | Full-Text PDF (82 KB)
Epidemiology and Cancer Prevention
Combined Pap and HPV testing in primary screening for cervical abnormalities: Should HPV detection be delayed until age 35? Marc F.D. Baay, Wiebren A.A. Tjalma, Hilde A.J. Lambrechts, Greet G.O. Pattyn, Filip Lardon, Joost Weyler, Paul Van Royen, Eric A.E. Van Marck, Jan B. Vermorken pages 2704-2708 Abstract | Full Text | Full-Text PDF (101 KB)
Incidence of pleural mesothelioma in Liguria Region, Italy (1996–2002) V. Gennaro, D. Ugolini, P. Viarengo, L. Benfatto, M. Bianchelli, A. Lazzarotto, F. Montanaro, R. Puntoni pages 2709-2714 Abstract | Full Text | Full-Text PDF (141 KB)
A population-based study from New South Wales, Australia 1996–2001: Area variation in survival from colorectal cancer Xue Q. Yu, Dianne L. O’Connell, Robert W. Gibberd, Bruce K. Armstrong pages 2715-2721 Abstract | Full Text | Full-Text PDF (112 KB)
Hospital variation in referral for primary radiotherapy in South Netherlands, 1988–1999 J.C.M. Vulto, W.J. Louwman, P.M.P. Poortmans, J.W.W. Coebergh pages 2722-2727 Abstract | Full Text | Full-Text PDF (169 KB)
Early diagnosis, not differential treatment, explains better survival in service screening Eugenio Paci, Antonio Ponti, Marco Zappa, Silvia Patriarca, Patrizia Falini, Gabriella Delmastro, Simonetta Bianchi, Anna Sapino, Vania Vezzosi, Carlo Senore, Emanuele Crocetti, Alfonso Frigerio, Roberto Zanetti, Marco Rosselli del Turco, Nereo Segnan pages 2728-2734 Abstract | Full Text | Full-Text PDF (112 KB)
Experimental Oncology
Inhibition of human androgen-independent PC-3 and DU-145 prostate cancers by antagonists of bombesin and growth hormone releasing hormone is linked to PKC, MAPK and c-jun intracellular signalling Anton Stangelberger, Andrew V. Schally, Jozsef L. Varga, Marta Zarandi, Ren-Zhi Cai, Benjamin Baker, Brian D. Hammann, Patricia Armatis, Celia A. Kanashiro pages 2735-2744 Abstract | Full Text | Full-Text PDF (279 KB)
PKA-dependent growth stimulation of cells derived from human pulmonary adenocarcinoma and small airway epithelium by dexamethasone H.A.N. Al-Wadei, T. Takahasi, H.M. Schuller pages 2745-2753 Abstract | Full Text | Full-Text PDF (455 KB)
Coordinate expression of the PI3-kinase downstream effectors serum and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer Sunati Sahoo, Deanna R. Brickley, Masha Kocherginsky, Suzanne D. Conzen pages 2754-2759 Abstract | Full Text | Full-Text PDF (1443 KB)
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer Matthias Kotzsch, Juliane Farthmann, Axel Meye, Susanne Fuessel, Gustavo Baretton, Vivianne C.G. Tjan-Heijnen, Manfred Schmitt, Thomas Luther, Fred C.G.J. Sweep, Viktor Magdolen, Paul N. Span pages 2760-2768 Abstract | Full Text | Full-Text PDF (150 KB)
Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma Martin G. Friedrich, Shahin Chandrasoma, Kimberly D. Siegmund, Daniel J. Weisenberger, Jonathan C. Cheng, Marieta I. Toma, Hartwig Huland, Peter A. Jones, Gangning Liang pages 2769-2778 Abstract | Full Text | Full-Text PDF (145 KB)
Calendar pages I-II Full-Text PDF (25 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
